RANKINGS

Lowest P/S — Healthcare

Price-to-Sales ratio measures valuation relative to revenue.

180 companies with P/S Ratio data.

Ranked by P/S Ratio(180)

#	Ticker	Name	Industry	Market Cap	P/S Ratio
1	IMCC	IM Cannabis Corp. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$954,195.18	0.0
2	SNYR	SYNERGY CHC CORP. TTM · 2026-03-31 Analysis WACC DCF	Pharmaceuticals	$1M	0.0
3	NAII	NATURAL ALTERNATIVES INTERNATIONAL INC FY · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$7M	0.1
4	TRIB	TRINITY BIOTECH PLC FY · 2024-12-31 Analysis WACC DCF	Biotechnology	$6M	0.1
5	AVD	AMERICAN VANGUARD CORPORATION TTM · 2026-06-30 Analysis WACC DCF	Other	$47M	0.1
6	MTEX	MANNATECH INC FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$15M	0.1
7	CRIS	CURIS, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$2M	0.2
8	BTMD	biote Corp. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$33M	0.2
9	VHI	VALHI, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$402M	0.2
10	GURE	GULF RESOURCES, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$5M	0.2
11	BHC	Bausch Health Companies Inc. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$2.3B	0.2
12	OLN	Olin Corporation TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$1.7B	0.3
13	USNA	USANA HEALTH SCIENCES, INC. TTM · 2026-07-04 Analysis WACC DCF	Pharmaceuticals	$271M	0.3
14	ALTO	ALTO INGREDIENTS, INC. FY · 2025-12-31 Analysis WACC DCF	Other	$289M	0.3
15	QDEL	QUIDELORTHO CORP TTM · 2026-06-28 Analysis WACC DCF	Biotechnology	$920M	0.3
16	FMC	FMC CORPORATION TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$1.3B	0.4
17	LFVN	LIFEVANTAGE CORP FY · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$76M	0.4
18	COTY	COTY INC. FY · 2026-06-30 Analysis WACC DCF	Other	$2.5B	0.4
19	SNDL	SNDL Inc. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$300M	0.4
20	NATR	NATURE’S SUNSHINE PRODUCTS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$222M	0.5
21	RMTI	ROCKWELL MEDICAL, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$32M	0.5
22	KRO	KRONOS WORLDWIDE, INC. FY · 2025-12-31 Analysis WACC DCF	Other	$876M	0.5
23	MOS	MOSAIC CO TTM · 2026-06-30 Analysis WACC DCF	Other	$6.0B	0.5
24	HRTX	HERON THERAPEUTICS, INC. /DE/ FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$77M	0.5
25	BON	BON NATURAL LIFE LIMITED FY · 2025-09-30 Analysis WACC DCF	Pharmaceuticals	$9M	0.5
26	MYGN	MYRIAD GENETICS, INC. TTM · 2026-06-30 Analysis WACC DCF	Biotechnology	$412M	0.5
27	DOW	DOW INC. FY · 2025-12-31 Analysis WACC DCF	Other	$20.5B	0.5
28	AMTX	AEMETIS, INC TTM · 2026-06-30 Analysis WACC DCF	Other	$120M	0.5
29	TLRY	Tilray Brands, Inc. FY · 2026-05-31 Analysis WACC DCF	Pharmaceuticals	$523M	0.6
30	SCL	STEPAN COMPANY FY · 2025-12-31 Analysis WACC DCF	Other	$1.4B	0.6
31	LYB	LYONDELLBASELL INDUSTRIES N.V. TTM · 2026-06-30 Analysis WACC DCF	Other	$19.4B	0.6
32	EPC	EDGEWELL PERSONAL CARE COMPANY TTM · 2026-06-30 Analysis WACC DCF	Other	$1.3B	0.6
33	FUL	FULLER H B CO TTM · 2026-08-29 Analysis WACC DCF	Other	$2.7B	0.8
34	EMN	EASTMAN CHEMICAL CO TTM · 2026-06-30 Analysis WACC DCF	Other	$7.2B	0.8
35	FTLF	FITLIFE BRANDS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$86M	0.9
36	SMG	Scotts Miracle-Gro Co TTM · 2026-06-27 Analysis WACC DCF	Other	$2.9B	0.9
37	MTX	MINERALS TECHNOLOGIES INC. TTM · 2026-07-05 Analysis WACC DCF	Other	$2.0B	0.9
38	SRPT	SAREPTA THERAPEUTICS, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$1.9B	1.0
39	PAHC	Phibro Animal Health Corporation FY · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$1.6B	1.0
40	GOVX	GEOVAX LABS, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$3M	1.0
41	AVNT	AVIENT CORPORATION FY · 2025-12-31 Analysis WACC DCF	Other	$3.5B	1.1
42	CBT	Cabot Corporation TTM · 2026-06-30 Analysis WACC DCF	Other	$3.9B	1.1
43	LXU	LSB Industries, Inc. TTM · 2026-06-30 Analysis WACC DCF	Other	$706M	1.1
44	CSBR	CHAMPIONS ONCOLOGY, INC. TTM · 2026-07-31 Analysis WACC DCF	Pharmaceuticals	$67M	1.1
45	NEUP	Neuphoria Therapeutics Inc. FY · 2025-06-30 Analysis WACC DCF	Pharmaceuticals	$18M	1.2
46	AMRN	AMARIN CORP PLC\UK FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$254M	1.2
47	LXFR	LUXFER HOLDINGS PLC TTM · 2026-03-29 Analysis WACC DCF	Other	$465M	1.3
48	TRAW	Traws Pharma, Inc. TTM · 2025-09-30 Analysis WACC DCF	Pharmaceuticals	$7M	1.3
49	SLSN	Solesence, Inc. TTM · 2026-06-30 Analysis WACC DCF	Other	$72M	1.3
50	IOSP	INNOSPEC INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$2.4B	1.3
51	VTRS	VIATRIS INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$20.3B	1.4
52	PPG	PPG INDUSTRIES INC TTM · 2026-03-31 Analysis WACC DCF	Other	$23.1B	1.4
53	ACNT	Ascent Industries Co. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$122M	1.5
54	CLX	CLOROX CO /DE/ TTM · 2026-03-31 Analysis WACC DCF	Other	$10.1B	1.5
55	RPM	RPM International Inc. TTM · 2026-08-31 Analysis WACC DCF	Other	$12.5B	1.5
56	MGNX	MACROGENICS, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$238M	1.6
57	NAGE	NIAGEN BIOSCIENCE, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$213M	1.6
58	CGC	Canopy Growth Corporation FY · 2026-03-31 Analysis WACC DCF	Pharmaceuticals	$350M	1.7
59	ANIP	ANI PHARMACEUTICALS, INC TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$1.7B	1.7
60	OPK	OPKO Health, Inc. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$1.0B	1.8
61	TOMZ	TOMI ENVIRONMENTAL SOLUTIONS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$13M	1.9
62	BMRA	BIOMERICA, INC. FY · 2026-05-31 Analysis WACC DCF	Biotechnology	$8M	1.9
63	LFCR	LIFECORE BIOMEDICAL, INC. FY · 2025-05-25 Analysis WACC DCF	Pharmaceuticals	$244M	1.9
64	SCYX	SCYNEXIS, Inc. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$41M	2.0
65	CDXS	Codexis, Inc. TTM · 2026-06-30 Analysis WACC DCF	Other	$154M	2.0
66	ALB	ALBEMARLE CORPORATION TTM · 2026-06-30 Analysis WACC DCF	Other	$12.0B	2.0
67	NL	NLI HOLDINGS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$339M	2.1
68	REX	REX AMERICAN RESOURCES CORPORATION TTM · 2026-07-31 Analysis WACC DCF	Other	$1.4B	2.1
69	FSI	FLEXIBLE SOLUTIONS INTERNATIONAL INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$77M	2.2
70	CF	CF INDUSTRIES HOLDINGS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$16.9B	2.2
71	KVUE	Kenvue Inc. TTM · 2026-06-28 Analysis WACC DCF	Other	$34.0B	2.2
72	BCRX	BIOCRYST PHARMACEUTICALS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$2.2B	2.3
73	IFF	INTERNATIONAL FLAVORS & FRAGRANCES INC TTM · 2026-06-30 Analysis WACC DCF	Other	$21.6B	2.4
74	EL	Estee Lauder Companies Inc FY · 2026-06-30 Analysis WACC DCF	Other	$35.5B	2.4
75	CPIX	Cumberland Pharmaceuticals Inc. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$105M	2.4
76	IPAR	INTERPARFUMS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$3.6B	2.4
77	BMY	BRISTOL-MYERS SQUIBB COMPANY TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$120.8B	2.5
78	SOLS	Solstice Advanced Materials Inc. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$9.7B	2.5
79	PFE	PFIZER INC TTM · 2026-06-28 Analysis WACC DCF	Pharmaceuticals	$161.2B	2.5
80	MNKD	MannKind Corporation TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$1.1B	2.7
81	TEVA	TEVA PHARMACEUTICAL INDUSTRIES LIMITED FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$47.9B	2.8
82	PLX	PROTALIX BIOTHERAPEUTICS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$224M	2.8
83	UG	UNITED-GUARDIAN, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$32M	2.9
84	NEOG	Neogen Corporation FY · 2026-05-31 Analysis WACC DCF	Biotechnology	$2.6B	3.0
85	ACAD	ACADIA PHARMACEUTICALS INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$3.4B	3.0
86	AGEN	AGENUS INC FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$346M	3.0
87	JAZZ	Jazz Pharmaceuticals plc TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$14.2B	3.1
88	BMRN	BIOMARIN PHARMACEUTICAL INC TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$10.6B	3.1
89	LAB	Standard BioTools Inc. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$271M	3.2
90	ROG	ROGERS CORP TTM · 2026-03-31 Analysis WACC DCF	Other	$2.6B	3.2
91	ICCC	ImmuCell Corporation FY · 2025-12-31 Analysis WACC DCF	Biotechnology	$89M	3.2
92	HXL	Hexcel Corporation TTM · 2026-06-30 Analysis WACC DCF	Other	$6.4B	3.2
93	ZTS	Zoetis Inc. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$30.9B	3.2
94	SXT	Sensient Technologies Corp TTM · 2026-06-30 Analysis WACC DCF	Other	$5.5B	3.3
95	FTK	FLOTEK INDUSTRIES INC/CN TTM · 2026-06-30 Analysis WACC DCF	Other	$970M	3.3
96	RIGL	RIGEL PHARMACEUTICALS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$917M	3.3
97	CL	COLGATE-PALMOLIVE COMPANY TTM · 2026-06-30 Analysis WACC DCF	Other	$70.4B	3.3
98	BIIB	BIOGEN INC. TTM · 2026-03-31 Analysis WACC DCF	Pharmaceuticals	$33.3B	3.4
99	VNRX	VOLITIONRX LIMITED FY · 2025-12-31 Analysis WACC DCF	Biotechnology	$6M	3.7
100	INVA	INNOVIVA, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$1.5B	3.7